6TSK
Beta-galactosidase in complex with L-ribose
6TSK の概要
| エントリーDOI | 10.2210/pdb6tsk/pdb |
| EMDBエントリー | 10563 10564 |
| 分子名称 | Beta-galactosidase, MAGNESIUM ION, beta-L-ribopyranose, ... (4 entities in total) |
| 機能のキーワード | bgal, l-ribose, sugar binding protein |
| 由来する生物種 | Escherichia coli |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 474279.08 |
| 構造登録者 | Saur, M.,Hartshorn, M.J.,Dong, J.,Reeks, J.,Bunkoczi, G.,Jhoti, H.,Williams, P.A. (登録日: 2019-12-20, 公開日: 2020-01-08, 最終更新日: 2024-05-22) |
| 主引用文献 | Saur, M.,Hartshorn, M.J.,Dong, J.,Reeks, J.,Bunkoczi, G.,Jhoti, H.,Williams, P.A. Fragment-based drug discovery using cryo-EM. Drug Discov Today, 25:485-490, 2020 Cited by PubMed Abstract: Recent advances in electron cryo-microscopy (cryo-EM) structure determination have pushed the resolutions obtainable by the method into the range widely considered to be of utility for drug discovery. Here, we review the use of cryo-EM in fragment-based drug discovery (FBDD) based on in-house method development. We demonstrate not only that cryo-EM can reveal details of the molecular interactions between fragments and a protein, but also that the current reproducibility, quality, and throughput are compatible with FBDD. We exemplify this using the test system β-galactosidase (Bgal) and the oncology target pyruvate kinase 2 (PKM2). PubMed: 31877353DOI: 10.1016/j.drudis.2019.12.006 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






